Inversion Recovery Ultrashort TE MR Imaging of Myelin is Significantly Correlated with Disability in Patients with Multiple Sclerosis

References

1. 1.↵
   1. van der Knaap MS,
   2. Valk J

   . Magnetic Resonance of Myelination and Myelin Disorders. Springer-Verlag; 2005: 1–19
2. 2.↵
   1. Nelson F,
   2. Poonawalla A,
   3. Hou P, et al

   . 3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult Scler 2008;14:1214–19 doi:10.1177/1352458508094644 pmid:8952832

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Thompson AJ,
   2. Miller DH,
   3. MacManus DG, et al

   . Patterns of disease activity in multiple sclerosis. BMJ 1990;301:44–45 doi:10.1136/bmj.301.6742.44-a pmid:2383714

   FREE Full Text
4. 4.↵
   1. Grossman RI,
   2. Braffman BH,
   3. Brorson JR, et al

   . Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology 1988;169:117–22 doi:10.1148/radiology.169.1.3420246 pmid:3420246

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Chen JT,
   2. Collins DL,
   3. Atkins HL, et al

   ; Canadian MS/BMT Study Group. Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Ann Neurol 2008;63:254–62 doi:10.1002/ana.21302 pmid:18257039

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Whittall KP,
   2. MacKay AL,
   3. Graeb DA, et al

   . In vivo measurement of T2 distributions and water contents in normal human brain. Magn Reson Med 1997;37:34–43 doi:10.1002/mrm.1910370107 pmid:8978630

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Hwang D,
   2. Kim DH,
   3. Du YP

   . In vivo multi-slice mapping of myelin water content using T2* decay. Neuroimage 2010;52:198–204 doi:10.1016/j.neuroimage.2010.04.023 pmid:20398770

   CrossRefPubMed
8. 8.↵
   1. Oh SJ,
   2. Bilello M,
   3. Schindler M, et al

   . Direct visualization of short transverse relaxation time component (ViSTa). Neuroimage 2013;83:485–92 doi:10.1016/j.neuroimage.2013.06.047 pmid:23796545

   CrossRefPubMed
9. 9.↵
   1. Ouellette R,
   2. Mangeat G,
   3. Polyak I, et al

   . Validation of rapid magnetic resonance myelin imaging in multiple sclerosis. Ann Neurol 2020;87:710–24 doi:10.1002/ana.25705 pmid:32057118

   CrossRefPubMed
10. 10.↵
    1. Miki Y,
    2. Grossman RI,
    3. Udupa JK, et al

    . Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images–lack of correlation between changes in T2 lesion volume and clinical findings. Radiology 1999;213:395–99 doi:10.1148/radiology.213.2.r99oc01395 pmid:10551218

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Li DK,
    2. Held U,
    3. Petkau J, et al

    ; Sylvia Lawry Centre for MS Research. MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology 2006;66:1384–89 doi:10.1212/01.wnl.0000210506.00078.5c pmid:16682671

    CrossRefPubMed
12. 12.↵
    1. Charil A,
    2. Zijdenbos AP,
    3. Taylor J, et al

    . Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 2003;19:532–44 doi:10.1016/S1053-8119(03)00117-4 pmid:12880785

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Poonawalla AH,
    2. Datta S,
    3. Juneja V, et al

    . Composite MRI scores improve correlation with EDSS in multiple sclerosis. Mult Scler 2010;16:1117–25 doi:10.1177/1352458510374892 pmid:20813778

    CrossRefPubMed
14. 14.↵
    1. Kappos L,
    2. Moeri D,
    3. Radue EW, et al

    . Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Lancet 1999;353:964–69 doi:10.1016/S0140-6736(98)03053-0 pmid:10459905

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Rovaris M,
    2. Judica E,
    3. Sastre-Garriga J, et al

    . Large-scale, multicenter, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. Mult Scler 2008;14:455–64 doi:10.1177/1352458507085129 pmid:18208869

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Waldman A,
    2. Rees JH,
    3. Brock CS, et al

    . MRI of the brain with ultra-short echo time pulse sequences. Neuroradiology 2003;45:887–92 doi:10.1007/s00234-003-1076-z pmid:14508620

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Horch RA,
    2. Gore JC,
    3. Does MD

    . Origins of the ultrashort T2 1H NMR signals in myelinated nerve: a direct measure of myelin content? Magn Reson Med 2011;66:24–31 doi:10.1002/mrm.22980 pmid:21574183

    CrossRefPubMed
18. 18.↵
    1. Wilhelm MJ,
    2. Ong HH,
    3. Wehrli SL, et al

    . Direct magnetic resonance detection of myelin and prospects for quantitative imaging of myelin density. Proc Natl Acad Sci U S A 2012;109:9605–10 doi:10.1073/pnas.1115107109 pmid:22628562

    Abstract/FREE Full Text
19. 19.↵
    1. Du J,
    2. Ma G,
    3. Li S, et al

    . Ultrashort TE echo time (UTE) magnetic resonance imaging of the short T2 components in white matter of the brain using a clinical 3T scanner. Neuroimage 2014;87:32–41 doi:10.1016/j.neuroimage.2013.10.053 pmid:24188809

    CrossRefPubMed
20. 20.↵
    1. Du J,
    2. Sheth V,
    3. He Q, et al

    . Measurement of T1 of the ultrashort T2* components in white matter of the brain at 3T. PLoS One 2014;9:e103296 doi:10.1371/journal.pone.0103296 pmid:25093859

    CrossRefPubMed
21. 21.↵
    1. Sheth V,
    2. Shao H,
    3. Chen J, et al

    . Magnetic resonance imaging of myelin using ultrashort echo time (UTE) pulse sequence: phantom, specimen, volunteers and multiple sclerosis patient studies. Neuroimage 2016;136:37–44 doi:10.1016/j.neuroimage.2016.05.012 pmid:27155128

    CrossRefPubMed
22. 22.↵
    1. Larson PE,
    2. Conolly SM,
    3. Pauly JM, et al

    . Using adiabatic inversion pulses for long-T2 suppression in ultrashort echo time (UTE) imaging. Magn Reson Med 2007;58:952–61 doi:10.1002/mrm.21341 pmid:17969119

    CrossRefPubMed
23. 23.↵
    1. Tustison NJ,
    2. Cook PA,
    3. Klein A, et al

    . Large-scale evaluation of ANTs and FreeSurfer cortical thickness measurements. Neuroimage 2014;99:166–79 doi:10.1016/j.neuroimage.2014.05.044 pmid:24879923

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Fonov VS,
    2. Evans AC,
    3. Botteron K, et al

    ; Brain Development Cooperative Group. Unbiased average age-appropriate atlases for pediatric studies. Neuroimage 2011;54:313–27 doi:10.1016/j.neuroimage.2010.07.033 pmid:20656036

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Avants BB,
    2. Tustison NJ,
    3. Wu J, et al

    . An open source multivariate framework for n-tissue segmentation with evaluation on public data. Neuroinformatics 2011;9:381–400 doi:10.1007/s12021-011-9109-y pmid:21373993

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Fukunaga M,
    2. Li TQ,
    3. Van Gelderen P, et al

    . Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A 2010;107:3834–39 doi:10.1073/pnas.0911177107 pmid:20133720

    Abstract/FREE Full Text
27. 27.↵
    1. Stüber C,
    2. Morawski M,
    3. Schäfer A, et al

    . Myelin and iron concentration in the human brain: a quantitative study of MRI contrast. Neuroimage 2014;93:95–106 doi:10.1016/j.neuroimage.2014.02.026 pmid:24607447

    CrossRefPubMed
28. 28.↵
    1. Acosta-Cabronero J,
    2. Betts MJ,
    3. Cardenas-Blanco A, et al

    . In vivo MRI mapping of brain iron deposition across the adult lifespan. J Neurosci 2016;36:364–74 doi:10.1523/JNEUROSCI.1907-15.2016 pmid:26758829

    Abstract/FREE Full Text
29. 29.↵
    1. Jang H,
    2. Drygalski A,
    3. Wong J, et al

    . Ultrashort echo time quantitative susceptibility mapping (UTE‐QSM) for detection of hemosiderin deposition in hemophilic arthropathy: a feasibility study. Magn Reson Med 2020;84:3246–55 doi:10.1002/mrm.28388 pmid:32662904

    CrossRefPubMed
30. 30.↵
    1. Jang H,
    2. Lu X,
    3. Carl M, et al

    . True phase quantitative susceptibility mapping using continuous single‐point imaging: a feasibility study. Magn Reson Med 2019;81:1907–14 doi:10.1002/mrm.27515 pmid:30325058

    CrossRefPubMed
31. 31.↵
    1. Latta P,
    2. Starcuk Z,
    3. Kojan M, et al

    . Simple compensation method for improved half-pulse excitation profile with rephrasing gradient. Magn Reson Med 2020;84:1796–1805 doi:10.1002/mrm.28233 pmid:32129544

    CrossRefPubMed
32. 32.↵
    1. Ma YJ,
    2. Searleman A,
    3. Jang H, et al

    . Whole-brain myelin mapping using 3D double echo sliding inversion recovery ultrashort echo time (DESIRE UTE) MRI. Radiology 2020;294:362–74 doi:10.1148/radiol.2019190911 pmid:31746689

    CrossRefPubMed
33. 33.↵
    1. Jang H,
    2. Wei Z,
    3. Wu M, et al

    . Improved volumetric myelin imaging in human brain using 3D dual echo inversion recovery-prepared UTE with complex echo subtraction. Magn Reson Med 2020;83:1168–77 doi:10.1002/mrm.28082 pmid:31746487

    CrossRefPubMed